U.S. Biological Safety Testing Products And Services Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Reagent & Kits, Services, Instruments), By Application (Stem Cell, Vaccines & Therapeutics, Gene Therapy), By Test Type, And Segment Forecasts

Table of Contents

Chapter 1. Methodology And Scope
                    1.1. Market Segmentation And Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Products Segment
                            1.1.1.2. Application Segment
                            1.1.1.3. Test Type Segment
                    1.2. Regional Scope
                    1.3. Estimates And Forecast Timeline
                    1.4. Objectives
                        1.4.1. Objective - 1
                        1.4.2. Objective - 2
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                        1.6.3. Secondary Sources
                        1.6.4. Primary Research
                    1.7. Information Or Data Analysis
                        1.7.1. Data Analysis Models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity Flow Analysis
                    1.10. List Of Primary Sources
                    1.11. List Of Abbreviations
Chapter 2. U.S. Biological Safety Testing Products & Services Market: Executive Summary
                    2.1. Market Snapshot
                    2.2. Products And Services Snapshots
                    2.3. Application and Test Type Snapshot
                    2.4. Competitive Landscape Snapshot
Chapter 3. U.S. Biological Safety Testing Products & Services Market Variables, Trends, & Scope
                    3.1. Market Segmentation And Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Dynamics
                    3.4. Market Drivers Analysis
                        3.4.1. Increase number of government initiatives and recommendations
                        3.4.2. Increasing production of new biologics due to high disease burden
                        3.4.3. High R&D investments in clinical research and life sciences research
                    3.5. Market Restraint Analysis
                        3.5.1. Time-consuming approval process
                            3.6. U.S. Biological Safety Testing Products & Services Market Analysis Tools
                        3.6.1. Industry Analysis - Porter’s
                            3.6.1.1. Supplier Power
                            3.6.1.2. Buyer Power
                            3.6.1.3. Substitution Threat
                            3.6.1.4. Threat Of New Entrant
                            3.6.1.5. Competitive Rivalry
                        3.6.2. PESTLE Analysis
                            3.6.2.1. Political Landscape
                            3.6.2.2. Technological Landscape
                            3.6.2.3. Economic Landscape
Chapter 4. U.S. Biological Safety Testing Products & Services: Products Estimates & Trend Analysis
                    4.1. Product Market Share, 2024 & 2033
                    4.2. Segment Dashboard
                            4.3. U.S. Biological Safety Testing Products & Services Market By Product Outlook
                    4.4. Market Size & Forecasts And Trend Analyses, 2021 To 2033 For The Following
                        4.4.1. Reagents & Kits
                            4.4.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        4.4.2. Services
                            4.4.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        4.4.3. Instruments
                            4.4.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
Chapter 5. U.S. Biological Safety Testing Products & Services: Application Estimates & Trend Analysis
                    5.1. Application Market Share, 2024 & 2033
                    5.2. Segment Dashboard
                    5.3. U.S. Biological Safety Testing Products & Services Market By Application Outlook
                    5.4. Market Size & Forecasts And Trend Analyses, 2021 To 2033 For The Following
                        5.4.1. Vaccine & Therapeutics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            5.4.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                                5.4.1.1.1. Vaccines Market Estimates And Forecasts 2021 To 2033 (USD Million)
                                    5.4.1.1.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                                5.4.1.1.2. Monoclonal Antibodies Market Estimates And Forecasts 2021 To 2033 (USD Million)
                                    5.4.1.1.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                                5.4.1.1.3. Recombinant Protein Market Estimates And Forecasts 2021 To 2033 (USD Million)
                                    5.4.1.1.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        5.4.2. Blood & Blood-based Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            5.4.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        5.4.3. Gene Therapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            5.4.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        5.4.4. Tissue & Tissue-based Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            5.4.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        5.4.5. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            5.4.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
Chapter 6. Biological Safety Testing Products & Services: Test Type Estimates & Trend Analysis
                    6.1. Test Type Market Share, 2024 & 2033
                    6.2. Segment Dashboard
                    6.3. Global U.S. Biological Safety Testing Products & Services Market By Test Type Outlook
                    6.4. Market Size & Forecasts And Trend Analyses, 2021 To 2033 For The Following
                        6.4.1. Endotoxin Tests
                            6.4.1.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        6.4.2. Sterility Tests
                            6.4.2.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        6.4.3. Cell Line Authentication & Characterization Tests
                            6.4.3.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        6.4.4. Bioburden Tests
                            6.4.4.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        6.4.5. Adventitious Agent Detection Tests
                            6.4.5.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        6.4.6. Residual Host Contamination Detection Tests
                            6.4.6.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
                        6.4.7. Others
                            6.4.7.1. Market Estimates And Forecasts 2021 To 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company /Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List Of Key Distributors And Channel Partners
                        7.3.2. Key Customers
                        7.3.3. Key Company Market Share Analysis, 2024
                        7.3.4. Charles River Laboratories
                            7.3.4.1. Overview
                            7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.4.3. Product Benchmarking
                            7.3.4.4. Strategic Initiatives
                        7.3.5. BSL Bioservice
                            7.3.5.1. Overview
                            7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.5.3. Product Benchmarking
                            7.3.5.4. Strategic Initiatives
                        7.3.6. Merck KGaA
                            7.3.6.1. Overview
                            7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.6.3. Product Benchmarking
                            7.3.6.4. Strategic Initiatives
                        7.3.7. Samsung Biologics
                            7.3.7.1. Overview
                            7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.7.3. Product Benchmarking
                            7.3.7.4. Strategic Initiatives
                        7.3.8. Sartorius AG
                            7.3.8.1. Overview
                            7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.8.3. Product Benchmarking
                            7.3.8.4. Strategic Initiatives
                        7.3.9. Eurofins Scientific
                            7.3.9.1. Overview
                            7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.9.3. Product Benchmarking
                            7.3.9.4. Strategic Initiatives
                        7.3.10. SGS Société Générale de Surveillance SA
                            7.3.10.1. Overview
                            7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.10.3. Product Benchmarking
                            7.3.10.4. Strategic Initiatives
                        7.3.11. Thermo Fisher Scientific Inc.
                            7.3.11.1. Overview
                            7.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.11.3. Product Benchmarking
                            7.3.11.4. Strategic Initiatives
                        7.3.12. BIOMÉRIEUX
                            7.3.12.1. Overview
                            7.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.12.3. Product Benchmarking
                            7.3.12.4. Strategic Initiatives
                        7.3.13. Lonza
                            7.3.13.1. Overview
                            7.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            7.3.13.3. Product Benchmarking
                            7.3.13.4. Strategic Initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 U.S. Biological Safety Testing Products and Services Market, by Product, 2021 - 2033 (USD Million)
Table 4 U.S. Biological Safety Testing Products and Services Market, by Application, 2021 - 2033 (USD Million)
Table 5 U.S. Biological Safety Testing Products and Services Market, by Test Type, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 U.S. Biological Safety Testing Products and Services Market Segmentation
Fig. 8 Market Snapshot, 2024
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2024
Fig. 16 U.S. Biological Safety Testing Products & Services Market: Product Movement Analysis
Fig. 17 U.S. Biological Safety Testing Products & Services Market: Product Outlook And Key Takeaways
Fig. 18 Reagents & Kits Market Estimates And Forecast, 2021 - 2033
Fig. 19 Services Estimates And Forecast, 2021 - 2033
Fig. 20 Instruments Estimates And Forecast, 2021 - 2033
Fig. 21 U.S. Biological Safety Testing Products & Services Market: Application Movement Analysis
Fig. 22 U.S. Biological Safety Testing Products & Services Market: Application Outlook And Key Takeaways
Fig. 23 Vaccines & therapeutics Market Estimates And Forecasts, 2021 - 2033
Fig. 24 Blood & Blood-based Products Market Estimates And Forecasts,2021 - 2033
Fig. 25 Gene Therapy Market Estimates And Forecasts,2021 - 2033
Fig. 26 Tissue & Tissue-based Products Market Estimates And Forecasts,2021 - 2033
Fig. 27 Stem Cell Market Estimates And Forecasts,2021 - 2033
Fig. 28 U.S. Biological Safety Testing Products & Services Market: Test Type Movement Analysis
Fig. 29 U.S. Biological Safety Testing Products & Services Market: End Use Outlook And Key Takeaways
Fig. 30 Endotoxin Tests Market Estimates And Forecasts, 2021 - 2033
Fig. 31 Sterility Tests Market Estimates And Forecasts,2021 - 2033
Fig. 32 Cell Line Authentication & Characterization Tests Estimates And Forecasts, 2021 - 2033
Fig. 33 Bioburden Tests Estimates And Forecasts, 2021 - 2033
Fig. 34 Adventitious Agent Detection Tests Estimates And Forecasts, 2021 - 2033
Fig. 35 Residual Host Contamination Detection Tests Estimates And Forecasts, 2021 - 2033
Fig. 36 Others Estimates And Forecasts, 2021 - 2033